Physiopathology of chemokine receptor interactions

2021 Kremer

 

Leonor Kremer

Group Leader

Contact

 

Research summary

Our main research interest is to understand how chemokines mediate the interaction between tumour cells and their microenvironment, and how they participate in the control of tumour growth and progression. We study the contribution of chemokine receptors to cancer cell physiology, and evaluate their potential as antitumor targets.

 

Publications

Santamaria S, Delgado M, Botas M, Castellano E, Corraliza-Gorjon I, Lafuente P, Muñoz-Calleja C, et al. Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumorsFront Immunol. 2022;13:825635.
 
Rubio-Ramos A, Bernabé-Rubio M, Labat-de-Hoz L, Casares-Arias J, Kremer L, Correas I, Alonso MA. MALL, a membrane-tetra-spanning proteolipid overexpressed in cancer, is present in membraneless nuclear biomolecular condensates. Cell Mol Life Sci. 2022;79:236. 
 
Cacho-Navas C, Reglero-Real N, Colás-Algora N, Barroso S, de Rivas G, Stamatakis K, Feito J, et al. Plasmolipin regulates basolateral-to-apical transcytosis of ICAM-1 and leukocyte adhesion in polarized hepatic epithelial cells. Cell Mol Life Sci. 2022;79:61. 

 

Perez-Zsolt D, Erkizia I, Pino M, García-Gallo M, Martin MT, et al. Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry. Nat Microbiol 2019; 4: 1558-1570.

Bárcena C, Aran G, Perea L, Sanjurjo L, Téllez É, et al. CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content. EBioMedicine 2019; 43:513-524.

Somovilla-Crespo B, Martín Monzón MT, VelaM, Corraliza-Gorjón I, Santamaria S, Garcia-Sanz JA, Kremer L. 92R Monoclonal Antibody Inhibits Human CCR9+ Leukemia Cells Growth in NSG Mice Xenografts. Front Immunol. 2018; 9:77.


More publications

 

Funding

Ministerio de Ciencia innovacion FEDER

 

 

 

Programa Estatal de I+D+i Orientada a los Retos de la Sociedad, del Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020.  Proyectos de I+D+i Retos Investigación, 2019. Generación de nuevas herramientas inmunoterapéuticas para el tratamiento de leucemias T-ALL"  (Referencia: PID2019-105404RB-I00).

 

 

Kremer Figura 1 2020 alta resolucion

Our group studies the role of chemokines and their receptors in tumour progression and metastasis, since they are involved in tumour cell survival and proliferation, tumour-associated angiogenesis and the antitumour immune response. There is growing interest in the development of new antibody-based immunotherapies for cancer treatment. We have generated a panel of mouse monoclonal antibodies (mAb) specific for the human CCR9 receptor, which is overexpressed in different haematological malignancies. Two antibodies that were selected for their efficacy in reducing the growth of human CCR9+ tumours in different immunodeficient mouse models have been protected by an international patent and have been licensed to SunRock Biopharma. Chimeric and humanised variants of these antibodies also effectively inhibit tumour growth. Recently, using the CRISPR/Cas9 system, we have generated tumour cell lines with modified variants of CCR9, which are being used in ongoing experiments on animal models to evaluate whether the candidate antibodies for clinical use exhibit any off-target side effects.

With the aim to generate antibody cocktails that can simultaneously attack different molecular targets on leukaemia cells, we generated mAb against surface antigens present on human T-cell acute lymphoblastic leukaemia cells. Several of them strongly reduce tumour size in animal models. Using proteomic techniques, we are selecting those mAb that recognise surface cell molecules with a greater therapeutic potential.

In collaboration with different research groups, we are also generating and evaluating mAb that can be used to modulate the immune response in other pathologies. We have contributed to analyse the role of the CCL1-CCR8 axis in atherosclerosis, to study CD5L in liver fibrosis and to generate new tools for inhibiting Ebola and HIV-1 viral uptake. We have also generated mAb against SARS-CoV-2 that are being evaluated as potential therapeutic agents for the treatment of COVID-19.

Kremer Figura 2 2020 alta resolucion

Figure legend: A. Stereomicroscopic images of a representative spleen from each treatment group, where the accumulation of tumour cells (MOLT-4-GFP+) in the isotype-control treated animals but not in the ChmAb-treated group, could be observed. Data from 3 mice of each 10 mice group are shown. B. Flow cytometry analyses of mouse bone marrow showing the fraction of MOLT-4-GFP+ cells from isotype control and ChmAb-treated animals. Data from 3 mice of each 10 mice group are shown.

 B0GrupoBaja 

Name
Position
Contact
Leonor Kremer Principal investigator
Isabel Corraliza Predoctoral student
Mercedes Llorente Technician
Elena Ramos Technician
María Teresa Martín Technician

NOTE! This site uses cookies and similar technologies.

If you continue browsing or do not change browser settings, we consider your acepptance for using. Learn more

I understand

COOKIES POLICY

A cookie is a text file that is stored on your computer or mobile device via a web server and only that server will be able to retrieve or read the contents of the cookie and allow the Web site remember browser preferences and navigate efficiently. Cookies make the interaction between the user and the website faster and easier.

General information

This Website uses cookies. Cookies are small text files generated by the web pages you visit, which contain the session data that can be useful later in the website. In this way this Web remembers information about your visit, which can facilitate your next visit and make the website more useful.

How do cookies?

Cookies can only store text, usually always anonymous and encrypted. No personal information is ever stored in a cookie, or can be associated with identified or identifiable person.

The data allow this website to keep your information between the pages, and also to discuss how to interact with the website. Cookies are safe because they can only store information that is put there by the browser, which is information the user entered in the browser or included in the page request. You can not run the code and can not be used to access your computer. If a website encrypts cookie data, only the website can read the information.

What types of cookies used?

The cookies used by this website can be distinguished by the following criteria:

1. Types of cookies as the entity that manages:

Depending on who the entity operating the computer or domain where cookies are sent and treat the data obtained, we can distinguish:

- Own cookies: are those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which provides the service requested by the user.

- Third party cookies: these are those that are sent to the user's terminal equipment from a machine or domain that is not managed by the publisher, but by another entity data is obtained through cookies.

In the event that the cookies are installed from a computer or domain managed by the editor itself but the information collected by these is managed by a third party can not be considered as party cookies.

2. Types of cookies as the length of time that remain active:

Depending on the length of time that remain active in the terminal equipment can be distinguished:

- Session cookies: cookies are a type designed to collect and store data while the user accesses a web page. Are usually used to store information that only worth preserving for the service requested by the user at any one time (eg a list of products purchased).

- Persistent cookies: cookies are a type of data which are stored in the terminal and can be accessed and treated for a period defined by the head of the cookie, and can range from a few minutes to several years.

3. Cookies types according to their purpose:

Depending on the purpose for which the data are processed through cookies, we can distinguish between:

- Technical cookies: these are those that allow the user to navigate through a web page or application platform and the use of different options or services it exist as, for example, control traffic and data communication, identify the session, access to restricted access parts, remember the elements of an order, make the buying process an order, make an application for registration or participation in an event, use security features while browsing store content for dissemination videos or sound or share content via social networks.

- Customization cookies: these are those that allow the user to access the service with some general characteristics based on a predefined set of criteria in the user terminal would eg language, the type of browser through which you access the service, the locale from which you access the service, etc.

- Analysis cookies: they are those that allow the responsible for them, monitoring and analyzing the behavior of users of the web sites that are linked. The information gathered through such cookies are used in measuring the activity of web sites, application or platform and for the profiling of user navigation of such sites, applications and platforms, in order to make improvements function data analysis how users use the service.

Management tool cookies

This Website uses Google Analytics.

Google Analytics is a free tool from Google that primarily allows website owners know how users interact with your website. Also, enable cookies in the domain of the site in which you are and uses a set of cookies called "__utma" and "__utmz" to collect information anonymously and reporting of website trends without identifying individual users..

For statistics of use of this website use cookies in order to know the level of recurrence of our visitors and more interesting content. This way we can concentrate our efforts on improving the most visited areas and make the user more easily find what they are looking for. On this site you can use the information from your visit for statistical evaluations and calculations anonymous data and to ensure the continuity of service or to make improvements to their websites. For more details, see the link below privacy policy [http://www.google.com/intl/en/policies/privacy/]

How to manage cookies on your computer: disabling and deleting cookies

All Internet browsers allow you to limit the behavior of a cookie or disable cookies within settings or browser settings. The steps for doing so are different for each browser, you can find instructions in the help menu of your browser.

If you decline the use of cookies, since it is possible thanks to the preferences menu of your browser or settings, reject, this website will continue to function properly without the use of the same.

Can you allow, block or delete cookies installed on your computer by setting your browser options installed on your computer:

- For more information about Internet Explorer click here.
- For more information on Chrome click here.
- For more information about Safari click here.
- For more information about Firefox click here.

Through your browser, you can also view the cookies that are on your computer, and delete them as you see fit. Cookies are text files, you can open and read the contents. The data within them is almost always encrypted with a numeric key corresponding to an Internet session so often has no meaning beyond the website who wrote it.

Informed consent

The use of this website on the other hand, implies that you paid your specific consent to the use of cookies, on the terms and conditions provided in this Cookies Policy, without prejudice to the measures of deactivation and removal of cookies that you can take, and mentioned in the previous section.